Navigation Links
Verenium Reports Financial Results for the First Quarter Ended March 31, 2011
Date:5/12/2011

SAN DIEGO, May 12, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported a summary of recent Company highlights and financial results for the first quarter ended March 31, 2011.

"I am pleased with the operational and financial progress made in the first quarter," said James E. Levine, President and Chief Executive Officer at Verenium. "Product revenues from our Grain and Oilseed Processing product lines continue to grow and our next-generation pipeline products have generated strong interest from potential partners. The trends towards higher commodity prices and increased demand for food and transportation fuels will continue to drive growth for products like ours, which provide the operating efficiencies customers value."

Company HighlightsSince the beginning of 2011, Verenium has made significant progress on both operational and financial fronts.  Recent accomplishments include:

Operational/Industry Performance:

Animal Health and Nutrition

  • Grew first quarter 2011 revenues from the Company's animal health and nutrition enzymes over the same period in 2010.

  • Grain Processing

  • Grew first quarter 2011 revenues from the Company's grain processing enzymes, including Fuelzyme® alpha-amylase, Deltazym® GA L-E5 glucoamylase, Veretase® alpha-amylase and Xylathin xylanase, by 26% over the same period in 2010; and
  • Grain processing has grown to represent 30% of 2011 product revenues.

  • Oilseed Processing

  • Achieved significant Purifine® phospholipase C (PLC) revenue growth over 2010 resulting from deployments by Molinos Rio de la Plata and Terminal 6, the
    '/>"/>

  • SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Verenium Announces 2010 Business Update and Outlook for 2011
    2. Verenium Announces Changes in Senior Management
    3. Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
    4. Verenium Corporation to Announce First Quarter 2011 Financial Results
    5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    6. Spherix Reports Second Quarter Earnings
    7. Tapestry Reports Second Quarter 2007 Results
    8. Callisto Reports on Second-Quarter 2007 Milestones
    9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
    (Date:12/17/2014)... Germany , December 17, 2014 ... level of expenditure on research and development In ... increased its revenue by two percent to EUR 4.287 billion ... (EBIT) grew by 14 percent to EUR 360 million. "Overall, ... said Dr. Michael Kaschke , President and CEO of ...
    (Date:12/17/2014)... 2014  Northstar Global Business Services, Inc. (OTCPink:MDIN) ... has made their final decision and has determined ... stock effective December 15, 2014, and has resumed ... and book entry transfer services. All deposit restrictions have ... again fully "DTC Eligible", and has resumed electronic ...
    Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3
    ... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
    ... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
    Cached Medicine Technology:
    (Date:12/19/2014)... Novellus Healthcare Communications, LLC announces the ... an independent journal that provides practical information for ... patients inside the pharmacy and retail clinics. ... access to quality care, Inside Patient Care: Pharmacy ... treating and coordinating patient care in pharmacies and ...
    (Date:12/19/2014)... Slone Partners , a national ... information technology, and laboratory testing industries, has promoted ... Officer. The announcement comes after a year of ... presence in Boston and several new additions to ... the client experience," said Adam Slone, Chief Executive ...
    (Date:12/19/2014)... good shape seems to reduce your risk of high blood ... than 57,000 Americans, including more than 35,000 with high blood ... Those in the poorest shape had a more than 70 ... of the study, compared to a 50 percent chance for ... than 8,000 people diagnosed with high blood pressure during the ...
    (Date:12/19/2014)... 18, 2014 (HealthDay News) -- Traveling through the same ... virus to three others within a four-hour time span, ... new report shows. "The exposures in this report ... than an international terminal, highlighting the fact that measles ... Vega, an infectious disease specialist at the U.S. Centers ...
    (Date:12/17/2014)... 17, 2014 Unidesk Corporation today ... (ACOM), which welcomed its inaugural class in August ... to seamlessly support bring your own device (BYOD) ... – experience. The solution, comprised of Citrix ... Dell server and storage infrastructure and ...
    Breaking Medicine News(10 mins):Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3
    ... April 15 SpectraScience, Inc. (OTC,Bulletin Board: SCIE), a San ... its annual shareholders meeting at 9:00 AM on,May 5, 2008 ... who held SpectraScience stock as of the close of business,on ... for the meeting are,entitled to attend in person., Jim ...
    ... waists. Healthier blood,pressure. Less risk for diabetes and ... for most adults. Here,s more on one popular ... Listen to this report from Apple Products Research ... journalists can access video, audio, text, graphics and,photos ...
    ... HealthSouth,Corporation (NYSE: HLS ) today announced it will ... on Wednesday, May 7, 2008, to discuss its,results for ... may be accessed by dialing 866-406-5369 and giving,the pass ... same pass code. Please call approximately 10 minutes before ...
    ... genetic determinants of resistance to the anti-cancer drug methotrexate ... pathway to predicting such resistance and treatments to overcome ... study. , Besides its use in ALL, methotrexate is ... diseases. However, until the new study there was no ...
    ... MODESTO, Calif., April 15 emebaVet, LLC, ... signage solutions and systems,integration, is teaming with ... pet forecasts from weather.com for their emebaVet,Client ... Interactive definitely enhances our emebaVet,Client Education System," ...
    ... Clothes Off Our Back(R) with Online ... Celebrity Shoe Auction, KENILWORTH, N.J., ... like one on the dance floor? DR. SCHOLL,S(R) FOR,HER and Julianne Hough, ... have partnered to raise money for,the charity foundation, Clothes Off Our Back(R). ...
    Cached Medicine News:Health News:Annual Shareholders Meeting to Be Held May 5, 2008 at the University Club in St. Paul, MN 2Health News:HealthSouth Announces Date of 2008 First Quarter Earnings Conference Call 2Health News:St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia 2Health News:St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia 3Health News:emebaVet Adds 'Pet Friendly' Forecast From the Weather Channel 2Health News:Video: Julianne Hough From Dancing With the Stars(TM) Has a New Partner: DR. SCHOLL'S(R) FOR HER 2Health News:Video: Julianne Hough From Dancing With the Stars(TM) Has a New Partner: DR. SCHOLL'S(R) FOR HER 3
    0.25 mm diameter textured tip with protective guard....
    ... design has been carefully considered with both the ... ensures the optimum viewing angle and the largest ... aligned for perfect focus where it is needed ... This along with Keeler's wide angle light ...
    A full function instrument at an economical price....
    ... The ophthalmoscope with superior aspherical optics. ... by means of the aspherical optical system ... Beta 200 allows you to view the ... retina even with a small pupil. Conventional ...
    Medicine Products: